Literature DB >> 30923038

Lung cancer: diagnosis and management: summary of updated NICE guidance.

Ross Maconachie1, Toby Mercer2, Neal Navani3, Gary McVeigh4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30923038     DOI： 10.1136/bmj.l1049

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line.

Authors:  Chengji Jin; Ping Song; Ji Pang
Journal:  Oncol Lett       Date:  2019-08-01       Impact factor: 2.967

Review 2.  COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary.

Authors:  Thomas Round; Veline L'Esperance; Joanne Bayly; Kate Brain; Lorraine Dallas; John G Edwards; Thomas Haswell; Crispin Hiley; Natasha Lovell; Julia McAdam; Grace McCutchan; Arjun Nair; Thomas Newsom-Davis; Elizabeth K Sage; Neal Navani
Journal:  Br J Cancer       Date:  2021-05-10       Impact factor: 7.640

Review 3.  The Cutting Edge of Thoracic Anesthesia During the Coronavirus Disease 2019 (COVID-19) Outbreak.

Authors:  Silvia Fiorelli; Cecilia Menna; Federico Piccioni; Mohsen Ibrahim; Erino Angelo Rendina; Monica Rocco; Domenico Massullo
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-06-07       Impact factor: 2.628

4.  Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.

Authors:  Stuart A Taylor; Sue Mallett; Simon Ball; Sandy Beare; Gauraang Bhatnagar; Angshu Bhowmik; Peter Boavida; John Bridgewater; Caroline S Clarke; Marian Duggan; Steve Ellis; Robert Glynne-Jones; Vicky Goh; Ashley M Groves; Ayshea Hameeduddin; Sam M Janes; Edward W Johnston; Dow-Mu Koh; Sara Lock; Anne Miles; Stephen Morris; Alison Morton; Neal Navani; Alfred Oliver; Terry O'Shaughnessy; Anwar R Padhani; David Prezzi; Shonit Punwani; Laura Quinn; Hameed Rafiee; Krystyna Reczko; Andrea G Rockall; Peter Russell; Harbir S Sidhu; Nicola Strickland; Kathryn Tarver; Jonathan Teague; Steve Halligan
Journal:  Lancet Respir Med       Date:  2019-05-09       Impact factor: 30.700

5.  Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis.

Authors:  Jie Pan; Yuan Bian; Zhuo Cao; Limei Lei; Jiongwei Pan; Jinwei Huang; Xiaoping Cai; Xiang Lan; Hao Zheng
Journal:  Thorac Cancer       Date:  2019-12-17       Impact factor: 3.500

Review 6.  Pearls and pitfalls in lung cancer staging.

Authors:  Lucian Beer; Ankush Jajodia; Helmut Prosch
Journal:  BJR Open       Date:  2020-07-08

Review 7.  Mediastinal staging for non-small cell lung cancer.

Authors:  Virginia Leiro-Fernández; Alberto Fernández-Villar
Journal:  Transl Lung Cancer Res       Date:  2021-01

8.  Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia.

Authors:  Wsam Ghandourh; Lois Holloway; Vikneswary Batumalai; Phillip Chlap; Matthew Field; Susannah Jacob
Journal:  Clin Transl Radiat Oncol       Date:  2022-03-05

9.  N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.

Authors:  Zhenyu Zhao; Qidong Cai; Pengfei Zhang; Boxue He; Xiong Peng; Guangxu Tu; Weilin Peng; Li Wang; Fenglei Yu; Xiang Wang
Journal:  Front Mol Biosci       Date:  2021-06-11

Review 10.  Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.

Authors:  Sanjay Popat; Neal Navani; Keith M Kerr; Egbert F Smit; Timothy J P Batchelor; Paul Van Schil; Suresh Senan; Fiona McDonald
Journal:  Oncologist       Date:  2020-11-21       Impact factor: 5.837
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.